Chairman; Hua | 全台幼兒園資訊網

2017年6月19日—EugeneHuang,chairman,andHua-LinWu,consultantofBlueBloodBiotechCorp.,provideinsightfulinformationonBB-101,aproteinproven ...

Eugene Huang, chairman, and Hua-Lin Wu, consultant of Blue Blood Biotech

Corp., provide insightful information on BB-101, a protein proven to be efficient for wound healing, while sharing their vision for the future growth of the company through partnerships with big pharmaceutical companies.

Could you introduce yourself to our executive readership?

Hua-Lin Wu (HLW): As a professor in Biochemistry and Molecular Biology in Taiwan, my research interest is in the study of biological functions of the proteins which closely related to vascular biology and wound healing. In the study of the protein expression in diabetic ulcer, we discovered several proteins that are of potential clinical interest. We are looking for the proteins that are up-regulated in the normal wound tissue but not in the diabetic ulcer. Luckily, we are able to identify some proteins of that category which we believed are drug targets for treatment of chronic wound that has critical unmet need.